Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1179
https://www.valueinhealthjournal.com/article/S1098-3015(14)03109-X/fulltext
Title :
Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03109-X&doi=10.1016/j.jval.2014.08.1179
First page :
A444
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
671